Medical device makers have been rushing to add AI to their products. While proponents say the new technology will revolutionize medicine, regulators are receiving a rising number of claims of patient ...

NEW ORLEANS , LA, UNITED STATES, January 29, 2026 /EINPresswire.com/ -- HeartLung Corporation announced today that ...

During a study session Monday, Aurora City Council moved forward with a proposed tobacco and vape retail licensing ordinance ...

Red light therapy has gone from dermatology clinics to the wellness world, promising everything from younger-looking skin and ...

As the field grows rapidly, companies are luring people from other nuclear industries and tapping the expanding educational ...

SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...

Dana-Farber Cancer Institute-led research helped drive an FDA label update for axicabtagene ciloleucel (Yescarta) that removes a prior exclusion for patients with primary central nervous system ...

This is the 1.5 mg starter dose of Wegovy’s new weight-loss pill. Novo Nordisk said it’s suing Hims & Hers Health for making knock-offs of its obesity medicines, even as Hims scrapped plans to sell a ...

Argá Medtech today announced positive findings from a first-in-human study of its Coherent Sine-Burst Electroporation (CSE) system.

Clear Street pointed to strength in RGX-202 data for Duchenne and early results from Sura-Vec in wet AMD.

TransMedics (Nasdaq:TMDX) received FDA investigational device exemption (IDE) for its next-generation OCS ENHANCE Heart trial.

According to court filings and Food and Drug Administration records, U.S. regulators have received more than 1,401 reports ...